Itaconate and obesity-related hormones promote tumor progression – new insights on metabolic dysfunction in early-onset colon cancer
IntroductionObesity is a strong risk factor for early-onset colon cancer (EOCC) and is associated with chronic inflammation largely mediated by macrophages. The macrophage-specific metabolite itaconate promotes growth in several types of cancer; however, its role in colon cancer (CC) is unknown. Her...
Saved in:
| Main Authors: | Katharina M. Scheurlen, Jacob Hallion, Dylan L. Snook, Anne MacLeod, Robert J. Beal, Mary A. Parks, Andrew B. Littlefield, Eliah Hiken, Adrian T. Billeter, Jeannette Bensen, Jeremy T. Gaskins, Julia Chariker, Eric C. Rouchka, Susan Galandiuk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1572985/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoparticle-based itaconate treatment recapitulates low-cholesterol/low-fat diet-induced atherosclerotic plaque resolution
by: Natalie E. Hong, et al.
Published: (2024-11-01) -
Epidemiologic and clinical profiles of colorectal cancer in Southern Egypt
by: Doris W. Chiu, et al.
Published: (2025-08-01) -
OncoE25: an AI model for predicting postoperative prognosis in early-onset stage I-III colon and rectal cancer—a population-based study using SEER with dual-center cohort validation
by: Luyun Yuan, et al.
Published: (2025-06-01) -
Rare BRAF gene fusions in metastatic early-onset colon cancer: A case report
by: Tingting Zhao, et al.
Published: (2024-12-01) -
Cell-based ELISpot protocol to detect and quantify antigen-specific antibody-secreting cells in murine whole-organ single-cell suspensions
by: Christina Brunner, et al.
Published: (2025-09-01)